Beta Bionics (BBNX) Net Margin (2024 - 2026)

Beta Bionics has disclosed Net Margin across 3 years of filings, most recently posting 79.26% for Q1 2026.

• Net Margin for Q1 2026 came in at 79.26%, up 1262.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 60.27% (up 1024.0% YoY), and the FY2025 annual result was 60.6%, up 289.0% from the prior year.
• Net Margin came in at 79.26% for Q1 2026 at Beta Bionics, down from 41.92% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 41.92% in Q4 2025 to a low of 91.88% in Q1 2025.
• The 3-year median for Net Margin is 64.29% (2024), against an average of 65.96%.
• Peak annual rise in Net Margin reached 1721 bps in 2025, while the deepest fall reached 2759 bps in 2025.
• Beta Bionics' Net Margin stood at 59.13% in 2024, then rose by 29 bps to 41.92% in 2025, then plunged by 89 bps to 79.26% in 2026.
• The last three Net Margin figures came in at 79.26% (Q1 2026), 41.92% (Q4 2025), and 52.14% (Q3 2025), per Business Quant data.